Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on October 14, 2025, Scienture Holdings, Inc. (the “ Company ”) received a written notice from the Listing Qualifications Staff (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1) (the “ Minimum Bid Price Requirement ”), as the minimum bid price of the Common Stock had been be…

Results of Operations and Financial Condition. On October 13, 2026, Scienture Holdings, Inc. issued a press release announcing certain preliminary financial results for the quarter ending September 30, 2026, and other recent operational highlights. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deem…

Material Modification to Rights of Security Holders. As previously disclosed, on November 18, 2025, the stockholders of Scienture Holdings, Inc. (the “ Company ”) approved a proposal to grant the Company’s board of directors (the “ Board ”) the discretion to amend the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s issued and outstanding shares of common stock, par value $0.00001 per share, at a ratio not less than one-for-two and not greater than one-f…

Regulation FD Disclosure. On September 30, 2026, the Company issued a press release announcing the Reverse Stock Split. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subj…

by reference. The information included in the Presentation is summary information that should be considered in the context of the Company’s filings with the Securities and Exchange Commission (the “ SEC ”) and other public announcements the Company has made or may make by press release or otherwise from time to time. The Presentation speaks as of the date of this Current Report on Form 8-K (this “ Current Report ”). While the Company may elect to update the Presentation in the future to refle…

Results of Operations and Financial Condition. On August 14, 2026, Scienture Holdings, Inc. issued a press release announcing its financial results for the quarter ending June 30, 2026, and other recent operational highlights. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purpose…

CFO — Eric Sherb: Eric Sherb resigned as CFO due to personal reasons.

Results of Operations and Financial Condition. On May 18, 2026, Scienture Holdings, Inc. issued a press release announcing its financial results for the quarter ending March 31, 2026, and other recent operational highlights. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes…

by reference. The information included in the Presentation is summary information that should be considered in the context of the Company’s filings with the Securities and Exchange Commission (the “ SEC ”) and other public announcements the Company has made or may make by press release or otherwise from time to time. The Presentation speaks as of the date of this Current Report on Form 8-K (this “ Current Report ”). While the Company may elect to update the Presentation in the future to refle…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On April 27, 2026, Scienture Holdings, Inc. (the “ Company ”) entered into and closed on a note purchase agreement (the “ Purchase Agreement ”) with Streeterville Capital, LLC, (the “ Lender ”) providing for the issuance of two secured promissory notes: (i) a Secured Promissory Note A-1 in the original principal amount of $8.42 million (the “ A-1 Note ”) and (ii) a Secured Promis…

Entry into a Material Definitive Agreement. The information provided in

by reference. The information included in the Presentation is summary information that should be considered in the context of the Company’s filings with the Securities and Exchange Commission (the “ SEC ”) and other public announcements the Company has made or may make by press release or otherwise from time to time. The Presentation speaks as of the date of this Current Report on Form 8-K (this “ Current Report ”). While the Company may elect to update the Presentation in the future to refle…

Other Events. On November 7, 2025, Scienture Holdings, Inc. (the “ Company ”) filed with the Securities and Exchange Commission a prospectus supplement to its Registration Statement on Form S-3 (Registration No. 333-289198) increasing the amount of shares of the Company’s common stock, par value $0.00001 per share, that the Company is eligible to sell pursuant to the equity distribution agreement with Maxim Group LLC, dated September 19, 2025, to an aggregate offering price of up to $150 mill…

Other Events. On October 24, 2025, Scienture Holdings, Inc. (the “ Company ”) filed with the Securities and Exchange Commission a prospectus supplement to its Registration Statement on Form S-3 (Registration No. 333-289198) increasing the amount of shares of the Company’s common stock, par value $0.00001 per share, that the Company is eligible to sell under General Instruction I.B.6 of Form S-3 and pursuant to the equity distribution agreement with Maxim Group LLC, dated September 19, 2025, t…

Termination of a Material Definitive Agreement. On October 20, 2025, Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (the “ Company ”), entered into (i) an amendment to that certain Employment Agreement by and between Scienture, LLC and Dr. Narasimhan Mani, the Company’s President and Co-Chief Executive Officer (the “ Mani Employment Amendment ”); and (ii) an amendment to that certain Employment Agreement by and between Scienture, LLC and Dr. Shankar Hariharan, the Compa…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On October 14, 2025, Scienture Holdings, Inc. (the “ Company ”) received a written notice from the Listing Qualifications department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1), as the minimum bid price of the Company’s common stock, par value $0.00001 (“ Common Stock ”) had been below $1.00 per share for 30…

Entry into a Material Definitive Agreement. The information provided in

Termination of a Material Definitive Agreement. As previously disclosed, Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (the “ Company ”), entered into a Loan and Security Agreement with NVK Finance LLC, a Nebraska Limited Liability Company (“ NVK ”) on September 8, 2023, as amended (the “ NVK Loan ”) involving a principal amount of $2,000,000. The original maturity of the NVK Loan was September 8, 2025. On October 10, 2025, the Company and Scienture, LLC entered into a…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. On October 14, 2025, the Company entered into and closed on a note purchase agreement (the “ Purchase Agreement ”) with Streeterville Capital, LLC, (the “ Lender ”), which provided for the issuance of a senior secured promissory note in the principal amount of $3,911,111.11 (the “ Note ”). The Note carries an original issue discount of $391,111.11. The Company agreed to pay $20,0…

Entry into a Material Definitive Agreement. As previously disclosed, Scienture Holdings, Inc. (the “ Company ”) issued 10% original issue discount secured convertible debentures (the “ Debentures ”) to Arena Finance Markets, LP and Arena Special Opportunities III LP (the “ Arena Investors ”) on November 25, 2024. On October 3, 2025, the Company entered into a letter agreement (the “ Agreement ”) with the Arena Investors whereby the Company and the Arena Investors agreed to amend Section 4(b)…

Entry Into A Material Definitive Agreement. On September 19, 2025, Scienture Holdings, Inc. (the “ Company ”) entered into an Equity Distribution Agreement (the “ Agreement ”) with Maxim Group LLC (the “ Manager ”) pursuant to which the Manager will act as the Company’s sole sales agent with respect to the offer and sale from time-to-time of shares of the Company’s common stock, par value $0.00001 per share, having an aggregate gross sales price of up to $9,200,000 (the “ Shares ”), which is…

Unregistered Sales of Equity Securities. As previously disclosed in the Current Report on Form 8-K filed by the Company on July 24, 2025, the Company’s board of directors previously approved an offering by the Company of shares of the Company’s Common Stock in an aggregate amount of up to $3,000,000 pursuant to a form of Common Stock Purchase Agreement (the “ Common Stock Purchase Agreement ”). Between July 18, 2025, and August 11, 2025, the Company entered into Common Stock Purchase Agreemen…

Entry into a Material Definitive Agreement. Securities Purchase Agreements. On August 13, 2025, Scienture Holdings, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with several institutional investors to sell in a registered direct offering an aggregate of 3,225,000 shares (the “ Shares ”) of the Company’s common stock, par value $0.00001 per share at a per share price $1.20 (the “ Offering ”). The Offering closed on August 15, 2025 (the “ Clos…

Regulation FD Disclosure. On July 24, 2025, the Company issued a press release announcing the capital raise. The press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference. The press release hall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise be subject to the liabilities of such Section 18. The information in this Item 7.01, as well as Exhibit 99…

Entry into a Material Definitive Agreement. The board of directors of Scienture Holdings, Inc. (the “ Company ”) recently approved a capital raise by the Company in an aggregate amount of up to $3,000,000 pursuant to a form of Common Stock Purchase Agreement (the “ Purchase Agreement ”). The Purchase Agreement provides that the Company would issue and sell, and investors would purchase, shares of the Company’s common stock, par value $0.00001 per share, for a price per share of $1.59. The Pur…